Acorda Therapeutics, Inc. Retained Earnings
Acorda Therapeutics, Inc. had Retained Earnings of -$1.22 billion as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-05-14
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$1.22B.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$1.19B.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$971.37M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$962.48M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-03-31 | -$1.22B 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$1.19B 10-Q · filed 2024-05-14 | |
| 2023-09-30 | -$971.37M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$962.48M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$953.10M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$936.27M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$955.41M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$941.56M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$894.88M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$870.36M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$849.79M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$822.72M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$799.86M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$766.40M 10-K · filed 2022-03-18 | |
| 2020-09-30 | -$683.36M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$690.70M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$673.28M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$666.81M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$732.47M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$468.93M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$441.45M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$393.84M 10-K · filed 2020-02-28 | |
| 2018-09-30 | -$403.44M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$389.53M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$435.73M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$455.11M 10-K · filed 2020-02-28 | |
| 2017-09-30 | -$284.15M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$258.95M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$250.76M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$243.97M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | -$240.88M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$228.15M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$209.87M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | -$209.35M 10-K · filed 2017-02-27 | |
| 2015-09-30 | -$218.56M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$222.50M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$223.50M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$220.41M 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$220.74M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$232.69M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$237.38M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$238.08M 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$244.27M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$251.75M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$255.66M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$254.52M 10-K · filed 2014-03-03 | |
| 2012-09-30 | -$387.50M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$397.09M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | -$401.63M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | -$409.48M 10-K · filed 2013-02-28 | |
| 2011-09-30 | -$422.18M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | -$441.04M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | -$440.76M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | -$440.09M 10-K · filed 2012-02-28 | -$440.09M 10-K · filed 2011-03-01 |
| 2010-09-30 | -$443.76M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | -$456.19M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | -$428.32M 10-K · filed 2011-03-01 |